Abstract
The expression of nm23 has been shown to correlate in some solid tumours with their metastatic potential and to be associated with a favourable prognosis in human breast cancer and melanoma. In breast and ovarian cancer nm23 expression is also correlated with lymph node involvement. We analysed the expression of nm23-H1 and -H2 in normal endometrium and in endometrial and cervical cancer by both Northern and Western blotting. Cellular localisation of Nm23-H1 was visualised by immunohistochemistry mostly in the cytoplasm. Both isoforms of Nm23 were present in all the samples analysed, and a clear direct correlation between Nm23-H1 and -H2 levels was evident. Median nm23-H2 levels were higher than than -H1 levels in both tissues. Cervical cancer patients with lymph node involvement were shown to have significantly lower protein levels of Nm23 (P < 0.007 for H1 and P < 0.009 for H2), and a similar trend was also evident in endometrial cancer. Furthermore, the degree of myometrial invasion in endometrial cancer patients was also inversely correlated with Nm23-H1 levels of expression (P < 0.003). Nm23 level may therefore be taken into consideration as a new marker in the prognostic characterisation and in the treatment planning of uterine tumour patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Marone, M., Scambia, G., Ferrandina, G. et al. Nm23 expression in endometrial and cervical cancer: inverse correlation with lymph node involvement and myometrial invasion. Br J Cancer 74, 1063–1068 (1996). https://doi.org/10.1038/bjc.1996.490
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.490
This article is cited by
-
Nme1 and Nme2 genes exert metastasis-suppressor activities in a genetically engineered mouse model of UV-induced melanoma
British Journal of Cancer (2021)
-
NDPKA is not just a metastasis suppressor – be aware of its metastasis-promoting role in neuroblastoma
Laboratory Investigation (2018)
-
Regulatory functions of Nm23-H2 in tumorigenesis: insights from biochemical to clinical perspectives
Naunyn-Schmiedeberg's Archives of Pharmacology (2015)
-
Mechanisms of non-metastatic 2 (NME2)-mediated control of metastasis across tumor types
Naunyn-Schmiedeberg's Archives of Pharmacology (2011)
-
Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival
BMC Cancer (2001)